• LAST PRICE
    4.3600
  • TODAY'S CHANGE (%)
    Trending Down-0.0500 (-1.1338%)
  • Bid / Lots
    4.2500/ 1
  • Ask / Lots
    4.4200/ 2
  • Open / Previous Close
    4.4800 / 4.4100
  • Day Range
    Low 4.2701
    High 4.5000
  • 52 Week Range
    Low 0.5300
    High 6.1000
  • Volume
    71,596
    below average

Search Criteria

Filter search criteria using below inputs

Click on magnifying glass icon to search

Search Criteria - - - Stocks (0)
CompanyCountrySymbol
Select an index
Price Comparison Graph. See accessible table below
1 Day Comparison Chart Accessibility Table. Thursday's close: 4.41
TimeVolumeRVPH
09:32 ET22154.48
09:39 ET1004.41
09:42 ET10174.41
09:50 ET4004.42
10:09 ET6664.44
10:15 ET6004.4324
10:18 ET7104.44
10:20 ET3794.455
10:22 ET22684.435
10:24 ET9904.42
10:26 ET13424.4
10:29 ET6004.4299
10:36 ET1954.4256
10:49 ET6004.43
10:51 ET7004.43
10:54 ET25004.4883
10:56 ET5004.4401
10:58 ET1004.43
11:09 ET50804.43
11:14 ET15004.4536
11:20 ET5004.43
11:21 ET3004.4188
11:25 ET4014.4
11:27 ET4524.4
11:30 ET7984.43
11:34 ET1004.425
11:38 ET3004.42
11:39 ET19104.4
11:57 ET1004.41
12:08 ET1514.4212
12:14 ET2734.42
12:17 ET3004.4054
12:26 ET1004.45
12:39 ET1004.45
12:44 ET10664.47
12:46 ET1004.5
12:51 ET7004.4664
12:53 ET1004.47
01:00 ET46934.4
01:02 ET5004.4299
01:04 ET1004.43
01:13 ET36504.35
01:27 ET4004.31
01:29 ET2504.34
01:31 ET1004.4
01:40 ET2004.39
01:51 ET2504.39
02:09 ET1004.34
02:18 ET5004.34
02:32 ET1014.275
02:34 ET1004.2762
02:36 ET7004.305
02:39 ET11004.28
02:43 ET1004.315
02:59 ET113844.4
03:14 ET3504.3113
03:21 ET1004.42
03:30 ET1004.41
03:33 ET1004.31
03:39 ET13004.3512
03:42 ET18004.36
03:46 ET1004.345
03:50 ET9504.3747
03:53 ET10004.34
03:55 ET2504.352
03:57 ET10004.3354
04:00 ET5004.36
Data delayed at least 15 minutes.
Industry Peers Overview Table
Company sortableMarket Cap sortableP/E Ratio (TTM) sortableEPS Growth (5yr) sortable
United StatesRVPH
Reviva Pharmaceuticals Holdings, Inc.
89.1M
-3.6x
---
United StatesLBPH
Longboard Pharmaceuticals Inc
89.3M
-2.1x
---
United StatesACHV
Achieve Life Sciences Inc
88.4M
-1.2x
---
United StatesPRTG
Portage Biotech Inc
87.7M
-5.2x
---
United StatesNCNA
NuCana PLC
73.6M
-1.9x
---
United StatesLYRA
Lyra Therapeutics Inc
85.0M
-1.2x
---
As of 2023-01-29

Company Information

Reviva Pharmaceuticals Holdings, Inc. is a clinical-stage biopharmaceutical company. The Company discovers, develops and seeks to commercialize therapeutics for diseases representing significant unmet medical needs. The Company’s pipeline is focused on the central nervous system, respiratory and metabolic diseases. The Company’s pipeline has two drug candidates, RP5063 (brilaroxazine) and RP1208. Its lead drug candidate, RP5063, is ready for continued clinical development for multiple neuropsychiatric indications. These include schizophrenia, bipolar disorder (BD), major depressive disorder (MDD), attention-deficit/hyperactivity disorder (ADHD), behavioral and psychotic symptoms of dementia or Alzheimer’s disease (BPSD), and Parkinson’s disease psychosis. Furthermore, RP5063 is also ready for clinical development for two respiratory indications, pulmonary arterial hypertension (PAH) and idiopathic pulmonary fibrosis (IPF). Its RP1208 drug candidate is a triple reuptake inhibitor (TRI).

Contact Information

Headquarters
19925 Stevens Creek Blvd., Suite 100CUPERTINO, CA, United States 95014
Phone
408-501-8881
Fax
408-904-6270

Executives

Independent Chairman of the Board
Parag Saxena
President, Chief Executive Officer, Director
Laxminarayan Bhat
Chief Financial Officer
Narayan Prabhu
Independent Director
Leslie Funtleyder
Independent Director
Richard Margolin

Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.

Open a New Account, or Login if you're a client.

You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.

Open a New Account, or Login if you're a client.

Fundamentals Table
Market Cap
$89.1M
Revenue (TTM)
$0.00
Shares Outstanding
20.4M
Dividend Yield
0.00%
Annual Dividend Rate
---
Ex-Dividend Date
01-01-01
Pay Date
01-01-01
Beta
0.08
EPS
$-1.22
Book Value
$1.99
P/E Ratio
-3.6x
Price/Sales (TTM)
---
Price/Cash Flow (TTM)
---
Operating Margin
---
*GAAP = prior to non-GAAP analyst adjusted earnings.

Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.

Open a New Account, or Login if you're a client.